Find generic entry opportunities
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Anticipate generic drug launch
Drug patents …
… from Kazakhstan to Kalamazoo
Proactively manage your pharmacy inventory
Manage your formulary budget
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
|Title:||Chemically modified small molecules|
|Abstract:||The invention provides small molecule drugs that are chemically modified by covalent attachment of a water-soluble oligomer obtained from a monodisperse or bimodal water-soluble oligomer composition. A conjugate of the invention, when administered by any of a number of administration routes, exhibits a reduced biological membrane crossing rate as compared to the biological membrane crossing rate of the small molecule drug not attached to the water-soluble oligomer.|
|Inventor(s):||Bentley; Michael D. (Huntsville, AL), Viegas; Tacey X. (Madison, AL), Goodin; Richard R. (Fayerville, TN), Cheng; Lin (Huntsville, AL), Zhao; Xuan (Huntsville, AL)|
|Assignee:||Nektar Therapeutics (San Carlos, CA)|
1. 6-CH.sub.3--(OCH.sub.2CH.sub.2).sub.7--O-Naloxol or a pharmaceutically acceptable salt thereof.
2. .alpha.-6-CH.sub.3--(OCH.sub.2CH.sub.2).sub.7--O-Naloxol or a pharmaceutically acceptable salt thereof.
3. .beta.-6-CH.sub.3--(OCH.sub.2CH.sub.2).sub.7--O-Naloxol or a pharmaceutically acceptable salt thereof.
4. A pharmaceutical composition comprising the compound of any one of claims 1-3, or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable excipient.